The quantitative analysis of crystallinity using FT-Raman spectroscopy

Pharmaceutical Research

Volumn 15, Issue 5, 1998, Pages 755-761

  Taylor, Lynne S ^a   Zografi, George ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Crystallinity; FT Raman spectroscopy; Indomethacin; Quantitation

Indexed keywords

INDOMETACIN;

ARTICLE; CRYSTAL STRUCTURE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG MIXTURE; DRUG STRUCTURE; PARTICLE SIZE; PHASE TRANSITION; POWDER; PRIORITY JOURNAL; QUANTITATIVE ASSAY; RAMAN SPECTROMETRY; STRUCTURE ACTIVITY RELATION; X RAY POWDER DIFFRACTION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CALORIMETRY, DIFFERENTIAL SCANNING; CRYSTALLOGRAPHY; INDOMETHACIN; REFERENCE VALUES; SPECTRUM ANALYSIS, RAMAN; STATISTICS;

EID: 0031750863     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011979221685     Document Type: Article

References (21)

1. B. C. Hancock and G. Zografi. Characteristics and significance of the amorphous state. J. Pharm. Sci. 86:1-12 (1997).
2. A. Saleki-Gerhardt, C. Ahlneck, and G. Zografi. Assessment of disorder in crystalline solids. Int. J. Pharm. 101:237-247 (1994).
3. H. P. Klug and L. E. Alexander. X-Ray diffraction procedures for polycrystalline and amorphous materials. Wiley, New York, 1974.
4. D. B. Black and E. G. Lovering. Estimation of the degree of crystallinity in digoxin by X-ray and infrared methods. J. Pharm. Pharmacol. 29:684-687 (1977).
5. T. Sebhatu, M. Angberg, and C. Alhneck. Assessment of the degree of disorder in crystalline solids by isothermal microcalorimetry. Int. J. Pharm. 104:135-144 (1994).
6. F. W. Langkilde, J. Sjöblom, L. Tekenbergs-Hjelte, and J. Mrak. Quantitative FT-Raman analysis of two crystal forms of a pharmaceutical compound. J. Pharm. Biomed. Anal. 15:687-696 (1997).
7. C. M. Deeley, R. A. Spragg, and T. L. Threlfall. A comparison of Fourier transform infrared and near-infrared Fourier transform Raman spectroscopy for quantitative measurements: an application in polymorphism. Spectrochimica Acta 47A: 1217-1223 (1991).
8. A. M. Tudor, S. J. Church, P. J. Hendra, M. C. Davies, and C. D. Melia. The qualitative and quantitative analysis of chlorpropamide mixtures by near-infrared Fourier transform Raman spectroscopy. Pharm. Res. 10:1772-1776 (1993).
9. L. S. Taylor and G. Zografi. Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions. Pharm. Res. 14:1691-1698 (1997).
10. D. E. Bugay, A. W. Newman, and P. Findlay. Quantitation of cefepime 2 HCl in cefepime 2HCl monohydrate by diffuse reflectance IR and powder X-ray diffraction techniques. J. Pharm. Biomed. Anal. 15:49-61 (1996).
11. M. Otsuka, T. Matsumoto, and N. Kaneniwa. Effect of environmental temperature on polymorphic solid-state transformation of indomethacin during grinding. Chem. Pharm. Bull 34:1784-1793 (1986).
12. M. Yoshioka, B. C. Hancock, and G. Zografi. Crystallization of indomethacin from the amorphous state below and above its glass transition temperature. J. Pharm. Sci. 83:1700-1705 (1994).
13. C. G. Kontoyannis, N. C. Bouropoulos, and P. G. Koutsoukos. Use of Raman spectroscopy for the quantitative analysis of calcium oxalate hydrates: application for the analysis of urinary stones. Appl. Spectrosc. 51:64-67 (1997).
14. R. Hüttenrauch, S. Fricke, and P. Zielke. Mechanical activation of pharmaceutical systems. Pharm. Res. 2:302-306 (1985).
15. J. C. Miller and J. N. Miller. Statistics for Analytical Chemistry. Ellis Horwood, New York 1993, pp. 101-139.
16. L. E. Briggner, G. Buckton, K. Bystrom, and P. Darcy. The use of isothermal microcalorimetry in the study of changes in crystallinity induced during the processing of powders. Int. J. Pharm. 105:125-135 (1994).
17. M. V. Pellow-Jarman, P. J. Hendra, and R. J. Lehnert. The dependence of Raman signal intensity on particle size for crystal powders. Vibrational Spectroscopy 12:257-261 (1996).
18. P. A. Hailey, P. Doherty, P. Tapsell., T. Oliver, and P. K. Aldridge. Automated system for the on-line monitoring of powder blending processes using near-infrared spectroscopy Part I. System development and control. J. Pharm. Biomed. Anal. 14:551-559 (1996).
19. D. J. Wargo and J. K. Drennen. Near-infrared spectroscopic characterization of pharmaceutical powder blends. J. Pharm. Biomed. Anal. 14:1415-1423 (1996).
20. M. C. Davies, J. S. Binns, C. D. Melia, P. J. Hendra, D. Bourgeois, S. P. Church, and P. J. Stephenson. FT Raman spectroscopy of drugs in polymers. Int. J. Pharm. 66:223-232 (1990).
21. P. J. Hendra. Fourier transform-Raman spectroscopy in pharmaceutical analysis and research. American Laboratory 28:17-24 (1996).